Medifast Launches Trilivy Metabolic Health System
BALTIMORE, July 17, 2026 Medifast, Inc. has announced the launch of Trilivy™, a comprehensive science-backed metabolic health system that...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
BALTIMORE, July 17, 2026 Medifast, Inc. has announced the launch of Trilivy™, a comprehensive science-backed metabolic health system that...
BOSTON, Mass., July 7, 2026 Handspring Health has secured $19 million in Series B financing, with Angelini Ventures participating...
FORT LAUDERDALE, Fla., July 7, 2026 Splash Beverage Group, Inc. has announced the acquisition of exclusive global licensing rights...
NEW YORK, July 7, 2026 The American Parkinson Disease Association (APDA) has announced the launch of “Bridging Mental Health...
NEW TAIPEI CITY, Taiwan, June 11, 2026 GlycoNex, Inc. (GNX) announced positive topline results from its Phase III clinical...
NEWPORT BEACH, Calif., June 11, 2026 Wave Neuroscience announced that the U.S. Food and Drug Administration (FDA) has granted...
